Health Care·Health Care Supplies·$5.6B
Bausch Lomb Corp (BLCO) is a healthcare company focused on eye health products, including contact lenses and surgical devices. With a market cap of $6 billion, it plays a significant role in the health care supplies sector, which is seeing increased demand as consumer spending on health and wellness rises.
EPS
Earnings per share (EPS) is a key indicator of the company's profitability and financial health.
Revenue
Revenue figures provide insight into the company's sales performance and market demand for its products.
Wall Street expectations, options signals, track record, and call prep available with Pro.
EPS Beat Streak
0Q
EPS Beat Rate
38%
Avg EPS Surprise
-76.74%
Avg Stock Reaction
-3.25%
In the last quarter, Bausch Lomb reported an EPS of $0.32, which was slightly below analyst expectations. The stock reacted negatively, dropping 0.34% the following day.
Management Promises & Guidance
Analysts are cautiously optimistic, expecting Bausch Lomb to report a modest EPS and revenue. However, the company has a mixed track record of meeting expectations.
Bull Case
If Bausch Lomb can exceed the EPS estimate, it may signal strong operational improvements and increased market demand, potentially boosting investor confidence.
Bear Case
Conversely, if the company misses expectations again, it could raise concerns about its growth trajectory and market competitiveness.
EPS
$0.05Earnings per share (EPS) is a key indicator of the company's profitability and financial health.
Revenue
$1.2BRevenue figures provide insight into the company's sales performance and market demand for its products.
The print will turn on these two things.
Q1
Will Bausch Lomb achieve an EPS of at least $0.05?
This figure is crucial for assessing the company's profitability and could influence investor sentiment significantly.
Q2
How does management view revenue growth in light of current market conditions?
Insights into revenue growth will provide clarity on the company's performance and future outlook, impacting stock performance.
Why consensus could be wrong
The Street may be underestimating the potential for Bausch Lomb to exceed its EPS expectations due to recent operational improvements not yet reflected in consensus estimates.
Supporting Evidence
Bausch Lomb has a history of surprising analysts, with a 13.92% beat last quarter.
The company's focus on innovation in eye health products could drive stronger sales than anticipated.
Key Risk
If revenue growth exceeds $1.3 billion, it could significantly alter the market's perception of the company's growth potential.
Pre-commit to what would confirm each case.
The market is weighing the company's ability to recover from past earnings misses and show consistent growth.
Bull Confirmed If
An EPS of $0.10 or higher would confirm strong operational performance and market demand.
Bear Confirmed If
An EPS below $0.02 would indicate ongoing challenges in meeting market expectations.
Implied Move
±4.2%
Currently, there is no options market data available to provide further insights.
Cross-company pattern from 30 similar setups.
Prior-quarter miss setup in Health Care
n=30Fade rate: 10 of 27 (37%)
This setup has occurred 30 times across Health Care in the last 2 years. 17 of 27 (63%) held or extended their move within 5 days — this setup typically holds direction. The average absolute 1-day move is 6.7%, with a raw directional average of +3.7% (modestly positive historical bias).
Likely market behavior by outcome — not investment advice.
Beat & Raise
If Bausch Lomb beats expectations, history suggests the stock could see a modest increase, confirming a positive turnaround narrative.
In-Line / Cautious
An in-line result may lead to a muted reaction, as investors await clearer guidance on future growth.
Miss
If the company misses expectations, the stock could drop, reflecting ongoing concerns about its performance, with an average move of -5.19% historically.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
VERIZON COMMUNICATIO
Apr 27, 2026